Skip to main content

Table 1 Patient demographic and clinical characteristics

From: Association of hypoglycemic symptoms with patients' rating of their health-related quality of life state: a cross sectional study

Characteristic All Patients
(N= 1709)
Spain
(N= 441)
France
(N= 150)
UK
(N= 342)
Norway
(N= 48)
Finland
(N= 162)
Germany
(N= 326)
Poland
(N= 240)
Age (years) 62.94 ± 10.58 63.21 ± 10.52 62.96 ± 10.06 62.80 ± 11.80 62.25 ± 9.57 61.74 ± 10.08 64.90 ± 10.21 60.93 ± 9.78
Female (%) 45.08 45.58 34.00 40.76 45.83 48.15 48.00 51.05
Current Smokers (%) 13.53 14.09 16.11 14.84 9.09 11.73 9.09 17.35
No Alcohol Use (%) 29.37 49.04 24.67 28.27 20.51 27.78 18.44 14.56
No Regular Physical Activity(%) 35.38 29.50 40.67 41.43 38.10 19.14 44.20 32.71
Physical Activity 3-5 Times/Week (%) 24.92 29.98 13.33 11.53 21.43 53.09 14.11 38.79
Body Mass Index (kg/m2) 31.7 ± 6.8 32.1 ± 7.5 31.0 ± 5.0 31.1 ± 6.9 30.8 ± 4.3 32.7 ± 5.6 31.6 ± 5.7 31.53 ± 8.3
Microvascular Events (%) 2.16 2.28 0.67 3.23 2.08 3.11 0.31 3.33
Cardiovascular Events (%) 26.39 18.68 26.00 30.79 22.92 25.47 25.39 38.25
Duration of T2DM (years) 7.84 ± 5.08 8.25 ± 5.13 8.43 ± 5.26 7.05 ± 4.95 8.19 ± 5.50 7.07 ± 3.95 9.15 ± 5.12 6.46 ± 5.03
HbA1c (%)* 7.06 ± 1.06 7.05 ± 1.20 7.00 ± 1.00 7.22 ± 1.07 7.31 ± 1.06 6.99 ± 1.05 7.02 ± 0.99 6.89 ± 0.88
Patients with HbA1c < 6.5% (%) 27.91 31.75 30.67 19.30 16.67 34.57 26.99 30.42
  1. *Refers to the most recent HbA1c measurement within the 12 months prior to visit
  2. Data are mean ± SD unless otherwise specified
  3. T2DM = type 2 diabetes mellitus; HbA1c = hemoglobin A1c